| Product Name |
Human Angiotensin-Converting Enzyme 2 (ACE2) Lentivirus |
| Description |
Recombinant lentivirus expressing human angiotensin-converting enzyme 2 (ACE2), a key receptor for SARS-CoV-2 viral entry. Produced in HEK293T cells with EGFP reporter for transduction efficiency monitoring. |
| Source |
HEK293T cells |
| Reporter |
EGFP (enhanced green fluorescent protein) |
| Applications |
- Screening of SARS-CoV-2 neutralizing antibodies
- Assessment of vaccine efficacy against ACE2-dependent variants
- Studies of viral entry mechanisms and receptor utilization
|
| Titer |
> 1 × 107 RFU/mL (relative fluorescence units) or > 1 × 105 TU/mL (transducing units) |
| Shipping |
Dry ice |
| Storage |
–80°C |
| References |
- Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein. Sci Rep 10, 19076 (2020). doi:10.1038/s41598-020-76135-w
- Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371(6531), 850-854 (2020). doi:10.1126/science.abf9302. PubMed: 33495308.
|